Metastasis-directed therapy for oligometastatic prostate cancer was associated with improved outcomes in a systematic review and meta-analysis.

PSA and Ki-67 tumour markers may identify high-risk metastatic castration-sensitive prostate cancer and inform treatment ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...

Shaka Hislop says it is "alarming" that tests for prostate cancer are not "regular and "standardised" in the United Kingdom.

Increasing use of blood tests to detect prostate cancer is leading to overworked doctors. Researchers at the Norwegian ...

Prostate cancer is still one of the most common cancers affecting men, yet new findings indicate that nutrition is significantly involved in its prevention, treatment, and recovery than most patients ...

Atherosclerosis, the gradual buildup of cholesterol-rich plaque inside artery walls, is the driving force behind most heart ...

Black men face the highest rate of prostate cancer diagnosis and death, with many being diagnosed at later stages due to a lack of awareness and access to screening, highlighting the need for more ...

Black men face the highest rate of prostate cancer diagnosis and death in the US, with many diagnosed at later stages due to lack of screening and prevention legislation, resulting in preventable ...

February is National Cancer Prevention Month and to help people keep life flowing smoothly, the Urology Care Foundation (UCF), the official foundation of the American Urological Association (AUA), is ...

Ostarine held the promise of profound medical treatments. Something unexpected happened on the way to F.D.A. approval.

Bone marrow metastasis (BMM) from non-hematolymphoid malignancies with resultant cytopenia(s) can mimic primary hematolymphoid disorders. This study aimed to investigate the clinical and pathological ...